🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3, multicenter, randomized, double-blind, placebo-controlle...
Status
Withdrawn
Location
Allakos Investigational Site
Start Date
2021-12
Trial ID
NCT05152563
This is a Phase 3, multi-center, randomized, double-blind, placebo-controll...
Status
Completed
Location
Allakos Investigational Site
Start Date
2021-05-20
Trial ID
NCT04856891
Single-centre, randomised, double blind, placebo controlled, single ascendi...
Status
Completed
Location
Nucleus Network Limited
Start Date
2016-08
Trial ID
NCT02859701
This is a Phase 2, double-blind, randomized, placebo-controlled study to as...
Status
Completed
Location
Phoenician Centers for Research and Innovation
Start Date
2018-07-18
Trial ID
NCT03496571
This is a Phase 1 study to investigate the safety and tolerability of AK002...
Status
Completed
Location
Charité - Universitätsmedizin Berlin
Start Date
2016-06
Trial ID
NCT02808793
Treatments Being Tested
This is a Phase 2/3, multi-center, randomized, double-blind, placebo-contro...
Status
Completed
Location
Allakos Investigational Site
Start Date
2020-07-06
Trial ID
NCT04322708
Treatments Being Tested
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Allakos Investigational Site 227-024
Start Date
2022-10-26
Trial ID
NCT05528861
Treatments Being Tested
This is a Phase 3, open-label, extension study to assess the long term effi...
Status
Completed
Location
Allakos Investigational Site 216-068
Start Date
2020-12-03
Trial ID
NCT04620811
Treatments Being Tested
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlle...
Status
Terminated
Location
Allakos Investigational Site 218-034
Start Date
2022-06-27
Trial ID
NCT05155085
This is a Phase 2, open-label, extension study to assess the safety and tol...
Status
Completed
Location
Phoenician Centers for Research and Innovation
Start Date
2018-11-14
Trial ID
NCT03664960
Treatments Being Tested